Design, synthesis and evaluation of novel dehydroabietic acid-dithiocarbamate hybrids as potential multi-targeted compounds for tumor cytotoxicity

In the present study, novel representatives of the important group of biologically-active, dehydroabietic acid-bearing dithiocarbamate moiety, were synthesized and characterized by 1H NMR, 13C NMR, HR-MS. The in vitro antiproliferative activity evaluation (MTT) indicated that these compounds exhibit...

Full description

Bibliographic Details
Main Authors: Chengyang Ni, YaJu Wu, Mei Ran, Jingyan Li, Hong Li, Cai Lan, Jian Liu, Ping Dai, Jianming Wu, Fangyao Li
Format: Article
Language:English
Published: Elsevier 2022-10-01
Series:Arabian Journal of Chemistry
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1878535222004610
_version_ 1818020612466016256
author Chengyang Ni
YaJu Wu
Mei Ran
Jingyan Li
Hong Li
Cai Lan
Jian Liu
Ping Dai
Jianming Wu
Fangyao Li
author_facet Chengyang Ni
YaJu Wu
Mei Ran
Jingyan Li
Hong Li
Cai Lan
Jian Liu
Ping Dai
Jianming Wu
Fangyao Li
author_sort Chengyang Ni
collection DOAJ
description In the present study, novel representatives of the important group of biologically-active, dehydroabietic acid-bearing dithiocarbamate moiety, were synthesized and characterized by 1H NMR, 13C NMR, HR-MS. The in vitro antiproliferative activity evaluation (MTT) indicated that these compounds exhibited potent inhibitory activities in various cancer cell lines (HepG-2, MCF-7, HeLa, T-24, MGC-803). Particularly, compound III-b possessed extraordinary cytotoxicity with low micromolar IC50 values ranging from 4.07 to 38.84 µM against tested cancer cell lines, while displayed weak cytotoxicity on two normal cell lines (LO-2 and HEK 293 T). Subsequently, the potential mechanisms of representative compound III-b were elementarily investigated by Transwell experiment, which showed III-b can inhibit cancer cells migration. Annexin-V/PI dual staining showed that the compound can induce HepG-2 cells apoptosis in a dose-dependent manner. Meanwhile this apoptosis may be related to the upregulated protein expression of cleaved-caspase 3, cleaved-caspase 9, Bax and downregulated of Bcl-2 indicated by Western Blot. Later study further confirmed that ROS levels in HepG-2 cells increased significantly with the rise of concentrations. In addition, through the network pharmacology data analyzing, the core targets and signaling pathways of compound III-b for treatment of liver neoplasms were forecasted. Molecular docking model showed that compound III-b had high affinity with hub targets (CASP3, EGFR, HSP90AA1, MAPK1, ERBB2, MDM2), suggesting that compound III-b might target the hub protein to modulate signaling activity. Taken together, these data indicated that dehydroabietic acid structural modification following the “Molecular hybridization” principle is a feasible way to discover the potential multi-targeted antitumor compounds.
first_indexed 2024-04-14T08:07:29Z
format Article
id doaj.art-bc37a983b3df4cecaa6bd9922b5047f6
institution Directory Open Access Journal
issn 1878-5352
language English
last_indexed 2024-04-14T08:07:29Z
publishDate 2022-10-01
publisher Elsevier
record_format Article
series Arabian Journal of Chemistry
spelling doaj.art-bc37a983b3df4cecaa6bd9922b5047f62022-12-22T02:04:41ZengElsevierArabian Journal of Chemistry1878-53522022-10-011510104145Design, synthesis and evaluation of novel dehydroabietic acid-dithiocarbamate hybrids as potential multi-targeted compounds for tumor cytotoxicityChengyang Ni0YaJu Wu1Mei Ran2Jingyan Li3Hong Li4Cai Lan5Jian Liu6Ping Dai7Jianming Wu8Fangyao Li9Sichuan Key Medical Laboratory of New Drug Discovery and Druggability, Luzhou Key Laboratory of Activity Screening and Druggability Evaluation for Chinese Materia Medica, School of Pharmacy, Southwest Medical University, Luzhou, China; School of Pharmacy, Guilin Medical University, Guilin, ChinaSchool of Pharmacy, Guilin Medical University, Guilin, ChinaSichuan Key Medical Laboratory of New Drug Discovery and Druggability, Luzhou Key Laboratory of Activity Screening and Druggability Evaluation for Chinese Materia Medica, School of Pharmacy, Southwest Medical University, Luzhou, ChinaSichuan Key Medical Laboratory of New Drug Discovery and Druggability, Luzhou Key Laboratory of Activity Screening and Druggability Evaluation for Chinese Materia Medica, School of Pharmacy, Southwest Medical University, Luzhou, China; Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, ThailandSichuan Key Medical Laboratory of New Drug Discovery and Druggability, Luzhou Key Laboratory of Activity Screening and Druggability Evaluation for Chinese Materia Medica, School of Pharmacy, Southwest Medical University, Luzhou, ChinaSichuan Key Medical Laboratory of New Drug Discovery and Druggability, Luzhou Key Laboratory of Activity Screening and Druggability Evaluation for Chinese Materia Medica, School of Pharmacy, Southwest Medical University, Luzhou, ChinaSichuan Key Medical Laboratory of New Drug Discovery and Druggability, Luzhou Key Laboratory of Activity Screening and Druggability Evaluation for Chinese Materia Medica, School of Pharmacy, Southwest Medical University, Luzhou, ChinaSchool of Pharmacy, Guilin Medical University, Guilin, China; Corresponding authors.Sichuan Key Medical Laboratory of New Drug Discovery and Druggability, Luzhou Key Laboratory of Activity Screening and Druggability Evaluation for Chinese Materia Medica, School of Pharmacy, Southwest Medical University, Luzhou, China; Corresponding authors.School of Pharmacy, Guilin Medical University, Guilin, China; Corresponding authors.In the present study, novel representatives of the important group of biologically-active, dehydroabietic acid-bearing dithiocarbamate moiety, were synthesized and characterized by 1H NMR, 13C NMR, HR-MS. The in vitro antiproliferative activity evaluation (MTT) indicated that these compounds exhibited potent inhibitory activities in various cancer cell lines (HepG-2, MCF-7, HeLa, T-24, MGC-803). Particularly, compound III-b possessed extraordinary cytotoxicity with low micromolar IC50 values ranging from 4.07 to 38.84 µM against tested cancer cell lines, while displayed weak cytotoxicity on two normal cell lines (LO-2 and HEK 293 T). Subsequently, the potential mechanisms of representative compound III-b were elementarily investigated by Transwell experiment, which showed III-b can inhibit cancer cells migration. Annexin-V/PI dual staining showed that the compound can induce HepG-2 cells apoptosis in a dose-dependent manner. Meanwhile this apoptosis may be related to the upregulated protein expression of cleaved-caspase 3, cleaved-caspase 9, Bax and downregulated of Bcl-2 indicated by Western Blot. Later study further confirmed that ROS levels in HepG-2 cells increased significantly with the rise of concentrations. In addition, through the network pharmacology data analyzing, the core targets and signaling pathways of compound III-b for treatment of liver neoplasms were forecasted. Molecular docking model showed that compound III-b had high affinity with hub targets (CASP3, EGFR, HSP90AA1, MAPK1, ERBB2, MDM2), suggesting that compound III-b might target the hub protein to modulate signaling activity. Taken together, these data indicated that dehydroabietic acid structural modification following the “Molecular hybridization” principle is a feasible way to discover the potential multi-targeted antitumor compounds.http://www.sciencedirect.com/science/article/pii/S1878535222004610Dehydroabietic AcidDithiocarbamateSynthesisAntitumor activityMolecular docking
spellingShingle Chengyang Ni
YaJu Wu
Mei Ran
Jingyan Li
Hong Li
Cai Lan
Jian Liu
Ping Dai
Jianming Wu
Fangyao Li
Design, synthesis and evaluation of novel dehydroabietic acid-dithiocarbamate hybrids as potential multi-targeted compounds for tumor cytotoxicity
Arabian Journal of Chemistry
Dehydroabietic Acid
Dithiocarbamate
Synthesis
Antitumor activity
Molecular docking
title Design, synthesis and evaluation of novel dehydroabietic acid-dithiocarbamate hybrids as potential multi-targeted compounds for tumor cytotoxicity
title_full Design, synthesis and evaluation of novel dehydroabietic acid-dithiocarbamate hybrids as potential multi-targeted compounds for tumor cytotoxicity
title_fullStr Design, synthesis and evaluation of novel dehydroabietic acid-dithiocarbamate hybrids as potential multi-targeted compounds for tumor cytotoxicity
title_full_unstemmed Design, synthesis and evaluation of novel dehydroabietic acid-dithiocarbamate hybrids as potential multi-targeted compounds for tumor cytotoxicity
title_short Design, synthesis and evaluation of novel dehydroabietic acid-dithiocarbamate hybrids as potential multi-targeted compounds for tumor cytotoxicity
title_sort design synthesis and evaluation of novel dehydroabietic acid dithiocarbamate hybrids as potential multi targeted compounds for tumor cytotoxicity
topic Dehydroabietic Acid
Dithiocarbamate
Synthesis
Antitumor activity
Molecular docking
url http://www.sciencedirect.com/science/article/pii/S1878535222004610
work_keys_str_mv AT chengyangni designsynthesisandevaluationofnoveldehydroabieticaciddithiocarbamatehybridsaspotentialmultitargetedcompoundsfortumorcytotoxicity
AT yajuwu designsynthesisandevaluationofnoveldehydroabieticaciddithiocarbamatehybridsaspotentialmultitargetedcompoundsfortumorcytotoxicity
AT meiran designsynthesisandevaluationofnoveldehydroabieticaciddithiocarbamatehybridsaspotentialmultitargetedcompoundsfortumorcytotoxicity
AT jingyanli designsynthesisandevaluationofnoveldehydroabieticaciddithiocarbamatehybridsaspotentialmultitargetedcompoundsfortumorcytotoxicity
AT hongli designsynthesisandevaluationofnoveldehydroabieticaciddithiocarbamatehybridsaspotentialmultitargetedcompoundsfortumorcytotoxicity
AT cailan designsynthesisandevaluationofnoveldehydroabieticaciddithiocarbamatehybridsaspotentialmultitargetedcompoundsfortumorcytotoxicity
AT jianliu designsynthesisandevaluationofnoveldehydroabieticaciddithiocarbamatehybridsaspotentialmultitargetedcompoundsfortumorcytotoxicity
AT pingdai designsynthesisandevaluationofnoveldehydroabieticaciddithiocarbamatehybridsaspotentialmultitargetedcompoundsfortumorcytotoxicity
AT jianmingwu designsynthesisandevaluationofnoveldehydroabieticaciddithiocarbamatehybridsaspotentialmultitargetedcompoundsfortumorcytotoxicity
AT fangyaoli designsynthesisandevaluationofnoveldehydroabieticaciddithiocarbamatehybridsaspotentialmultitargetedcompoundsfortumorcytotoxicity